Journal of Korean society of Dental Hygiene (한국치위생학회지)

Korean Society of Dental Hygiene (한국치위생학회)
권호 표지
DOI QR코드

DOI QR Code

Anticancer effect of methanol extract of Erigeron bonariensis on oral cancer cells

구강암 세포주에서 실망초 추출물의 항암효능

  • Received : 2020.08.24
  • Accepted : 2020.09.30
  • Published : 2020.10.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: Erigeron bonariensis is a type of Erigeron found throughout the tropical and subtropical areas as one of the perennial plants or pioneer plants. It is known to show detoxifying, antipyretic, and anticancer effects for various cancers. However, there are no reports on the anticancer effect of E. bonariensis on oral cancer cells. In the present study, we investigated the effects of the methanol extract of Erigeron bonariensis (MEEB) on the inhibition of cell growth and induction of apoptosis in mucoepidermoid carcinoma (MEC) cell lines, including the MC3 and YD15 oral cancer cells. Methods: MC3 Cells were treated by dimethyl sulfoxide (DMSO) or methanol extracts of 20 various natural products 20 ㎍/mL for 48 hours and cell viability were analyzed as Trypan blue exclusion assay. The effects of MEEB treatment on the cell viability of MC3 and YD15 cells, for 48 h, were analyzed by Trypan blue exclusion assay. The anticancer efficacy and apoptosis of oral cancer cell lines were analyzed by western blot analysis. The statistical significance of differences between groups was analyzed by Student's two-tailed t-test. A value of P<0.05 compared to the vehicle control was considered statistically significant. Results: Among 20 different naturally derived products, MEEB significantly inhibited cell viability and increased cleaved poly [ADP-ribose] polymerase 1 (PARP) protein in the MC3 and YD15 cells in a concentration-dependent manner. Conclusions: These results suggest that MEEB can be used as a natural anticancer drug for the treatment of human oral cancer.

Keywords

References

  1. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 2009;45(4-5):309-16. https://doi.org/10.1016/j.oraloncology.2008.06.002
  2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127(12):2893-917. https://doi.org/10.1002/ijc.25516
  3. Cho KH. Lysophosphatidic acid-induced TWIST1 and slug expression in oral cancer cell invasion. J Dent Hyg Sci 2017;17(5):433-8. https://doi.org/10.17135/jdhs.2017.17.5.433
  4. Choi ES, Oh S, Jang B, Yu HJ, Shin JA, Cho NP, et al. Silymarin and its active component silibinin act as novel therapeutic alternatives for salivary gland cancer by targeting the ERK1/2-Bim signaling cascade. Cell Oncol (Dordr) 2017;40(3):235-46. https://doi.org/10.1007/s13402-017-0318-8
  5. Lujan B, Hakim S, Moyano S, Nadal A, Caballero M, Diaz A, et al. Activation of the EGFR/ERK pathway in high-grade mucoepidermoid carcinomas of the salivary glands. Br J Cancer 2010;103(4):510-6. https://doi.org/10.1038/sj.bjc.6605788
  6. Kim J, Park YM, Lim DS. Purification of materials produced by amylocolatosis sp. and anticancer effect in oral cancer model. J Dent Hyg Sci 2003;3(1):11-4.
  7. Shen J, Huang C, Jiang L, Gao F, Wang Z, Zhang Y, et al. Enhancement of cisplatin induced apoptosis by suberoylanilide hydroxamic acid in human oral squamous cell carcinoma cell lines. Biochem Pharmacol 2007;73(12):1901-9. https://doi.org/10.1016/j.bcp.2007.03.009
  8. Lee HE, Shin JA, Jeong JH, Jeon JG, Lee MH, Cho SD. Anticancer activity of ashwagandha against human head and neck cancer cell lines. J Oral Pathol Med 2016;45(3):193-201. https://doi.org/10.1111/jop.12353
  9. Shin JA, Shim JH, Jeon JG, Choi KH, Choi ES, Cho NP, et al. Apoptotic effect of polygonum cuspidatum in oral cancer cells through the regulation of specificity protein 1. Oral Dis 2011;17(2):162-70. https://doi.org/10.1111/j.1601-0825.2010.01710.x
  10. Lee HB, Kim JC, Lee SM. Antibacterial activity of two phloroglucinols, flavaspidic acids AB and PB, from dryopteris crassirhizoma. Arch Pharm Res 2009;32(5):655-9. https://doi.org/10.1007/s12272-009-1502-9
  11. Min BS, Tomiyama M, Ma CM, Nakamura N, Hattori M. Kaempferol. Acetylrhamnosides from the rhizome of dryopteris crassirhizoma and their inhibitory effects on three different activities of human immunodeficiency virus-1 reverse transcriptase. Chem Pharm Bull (Tokyo) 2001;49(5):546-50. https://doi.org/10.1248/cpb.49.546
  12. Agarwal R, Agarwal C, Ichikawa H, Singh RP, Aggarwal BB. Anticancer potential of silymarin: from bench to bed side. Anticancer Res 2006;26(6B):4457-98.
  13. Hajdu Z, Hohmann J, Forgo P, Mathe I, Molnar J, Zupko I. Antiproliferative activity of artemisia asiatica extract and its constituents on human tumor cell lines. Planta Med 2014;80(18):1692-7. https://doi.org/10.1055/s-0034-1383146
  14. Ooi KL, Loh SI, Tan ML, Muhammad TS, Sulaiman SF. Growth inhibition of human liver carcinoma HepG2 cells and alpha-glucosidase inhibitory activity of murdannia bracteata (C.B. Clarke) Kuntze ex J.K. Morton extracts. J Ethnopharmacol 2015;162: 55-60. https://doi.org/10.1016/j.jep.2014.12.030
  15. Van Ginkel PR, Yan MB, Bhattacharya S, Polans AS, Kenealey JD. Natural products induce a G proteinmediated calcium pathway activating p53 in cancer cells. Toxicol Appl Pharmacol 2015;288(3):453-62. https://doi.org/10.1016/j.taap.2015.08.016
  16. Lee YH, Hong SH, Na CS, Sohn SI, Kim MH, Kim CS, et al. Predicting the suitable habitat of invasive alien plant conyza bonariensis based on climate change scenarios. J Climate Change Res 2015;6(3):243-8. https://doi.org/10.15531/KSCCR.2015.6.3.243
  17. Nazaruk J, Kalemba D. Chemical composition of the essential oils from the roots of Erigeron acris L. and Erigeron annuus (L.) Pers. Molecules 2009;14(7):2458-65. https://doi.org/10.3390/molecules14072458
  18. Bukhari IA, Shah AJ, Khan RA, Meo SA, Khan A, Gilani AH. Gut modulator effects of Conyza bonariensis explain its traditional use in constipation and diarrhea. Eur Rev Med Pharmacol Sci 2013;17(4):552-8.
  19. Csupor-Loffler B, Hajdu Z, Rethy B, Zupko I, Mathe I, Redei T, et al. Antiproliferative activity of hungarian asteraceae species against human cancer cell lines. Part II. Phytother Res 2009;23(8):1109-15. https://doi.org/10.1002/ptr.2755
  20. Sohn SH, Ko E, Oh BG, Kim J, Choi E, Kim SH, et al. Global gene analysis of Erigeron canadensis-treated TNF-alpha-, IL-4- and IL-1beta-stimulated A549 human epithelial cells. Ann Nutr Metab 2009;54(3):227-35. https://doi.org/10.1159/000225378
  21. Chaitanya GV, Steven AJ, Babu PP. PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration. Cell Commun Signal 2010;8:31. https://doi.org/10.1186/1478-811X-8-31
  22. Ovadje P, Roma A, Steckle M, Nicoletti L, Arnason JT, Pandey S. Advances in the research and development of natural health products as main stream cancer therapeutics. Evid Based Complement Alternat Med 2015;2015:751348. https://doi.org/10.1155/2015/751348
  23. Lee HO, Chun JY, Lee JY, Kim CH. Cytotoxicity on cancer cells of the extract of sophora flavescens ait. J Dent Hyg Sci 2002;2(1):1-5.
  24. Igney FH, Krammer PH. Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer 2002;2(4):277-88. https://doi.org/10.1038/nrc776
  25. Cha JD, Kim JY. Essential oil from cryptomeria japonica induces apoptosis in human oral epidermoid carcinoma cells via mitochondrial stress and activation of caspases. Molecules 2012;17(4):3890-901. https://doi.org/10.3390/molecules17043890